GHV Quarterly External Newsletter March 2025

GHV Quarterly External Newsletter March 2025

Dear friends,

Welcome to the latest edition of the GHV Newsletter! This quarter we’re focusing on the pivotal role pharma can play in fostering impactful partnerships to enhance global health outcomes. Be sure to register for our upcoming webinar with experts from AstraZeneca, the Gates Foundation, and Merck; explore our new insights paper; check out this month’s team spotlights; and hear from our CEO about how GHV is responding to the crisis in international development. We hope you enjoy it.

Thank you for being part of our community!

Warm regards, The GHV Team


GHV Webinar

We hope you’ll join us for an engaging conversation!

The pharmaceutical sector is rapidly evolving, embracing AI, digital health tools, and other innovations to expand global health access and improve outcomes.?Hear from these?experts in the pharma industry and global health community as they explore how these technologies are shaping the future of healthcare:

Don’t miss this opportunity to hear how leading pharmaceutical companies are driving innovation, improving access, and preparing for the future.?Register today!

Register here for the webinar


GHV Insights Paper

Partnering Better: Ten Principles for Impactful Global Health Partnerships

How pharma and other private sector health companies can build innovative, inclusive, and impactful global health partnerships


In the face of diminishing global health financing and increasingly complex health challenges, pharmaceutical companies (pharma) can play a pivotal role in fostering impactful partnerships to enhance global health outcomes. By collaborating with NGOs, governments, academia, philanthropies, and other private sector entities, these companies can leverage collective expertise and resources to address pressing health issues. Our latest insights paper outlines ten principles designed to guide pharmaceutical companies in establishing highly impactful, inclusive, and innovative partnerships.

Read the insights paper here


Team Spotlight

Rahima F. Dosani

Meet GHV’s Director of Strategy, Innovation, and Learning – Rahima Dosani. From diagnostics and supply chain to pandemic preparedness, Rahima has deep experience in global health. She leads the Global Health Innovations portfolio, focusing on scaling innovative solutions that drive equity and impact in global health. Rahima also brings significant expertise partnering with pharmaceutical and diagnostics companies, where she has worked to create partnerships strategies, enhance social impact alignment, and advocate for more R&D funding for global health.

Read the spotlight


Anjali Desai


Meet Senior Consultant Anjali Desai. At GHV, we believe that driving meaningful change in global health requires collaboration across sectors, deep community engagement, and strategies that bridge policy and action. Few people embody this more than Anjali, a senior consultant whose career has spanned public health policy, advocacy, and multi-sector partnerships.?Anjali’s expertise extends to pharma partnerships as well. She has supported pharma partners through the transition of an outbreak vaccine from investigational use to licensure, ensuring that key stakeholders were engaged at every stage.

Read the spotlight


GHV Expertise

Powering a Healthier, More Equitable World

GHV helps pharma companies and foundations increase access and equity in global health by creating strategic and operational plans, facilitating meaningful partnerships, and measuring and communicating impact – driving key outcomes such as access to medicines, health systems strengthening, and global health pipelines. To learn more, see our latest two-pager.


Learn More


Other News

A Note from Our CEO

Nejla Liias

Like many of you, I’ve been shocked and saddened by the Trump administration’s impulsive actions over the last few weeks with regard to critical domestic and foreign programs. As the CEO of a company committed to improving lives all over the world, I am particularly disheartened at the sheer disregard for human lives and livelihoods. The executive orders that will impact global health and development – including withdrawing from the WHO, suspending USAID work and contracts, halting ?treatments to individuals living with HIV/AIDs, withdrawing from the Paris Agreement, and rejoining of the Geneva Consensus – each are having real and direct impacts immediately on the lives of Americans in the loss of thousands of important jobs, as well as on individuals who rely on these commitments all over the world.

At GHV we are guided by a vision that the fundamental rights to a healthy life, healthy community, and healthy planet are equally available to all. We’ve been honored to work with partners around the world who share that vision and work tirelessly alongside underserved communities to improve their health and wellbeing and that of the environment. We believe in the interconnectedness of all living things and that when one suffers, we all suffer. We believe in justice, equity, diversity, and inclusion, recognizing that with privilege comes responsibility. As the country with the largest GDP in the world, the United States has the responsibility not only to care for our citizens at home but also offer support to low- and middle-income countries. These are investments, not charity. We’ve seen time and again that the health of people and the environment are not contained by national borders. When we work together, we all benefit. When we don’t, lives are needlessly lost and ecosystems damaged. While we can’t undo what has been done in the immediate, we welcome the backlash we’re seeing against these radical moves. We stand with our partners and global communities affected by work stoppages and divestments: we see you, we value you, and our hearts are with you. For now, we will continue to monitor these actions and share what we know, as shared knowledge is the foundation of collective action.


A New Brand for Broader Impact

As GHV continues to expand its partnerships beyond global health, we are embarking on a rebrand to better reflect the breadth of our work and the diverse organizations we support. From foundations and NGOs to multilateral institutions and private sector partners, our work now spans a wider range of development challenges, including environmental and climate-focused initiatives. This rebrand will strengthen our identity as a trusted, dynamic, and innovative consulting firm, deepening engagement with existing partners while welcoming new collaborations across the Global South and beyond. Stay tuned for more updates as we shape the future of GHV!


Upcoming Days and Events


Recognition Days

March

8?–?International Women’s Day

14?– Equal Pay Day

14?– Black Midwives Day

31?– International Transgender Day of Visibility

?

April

7??World Health Day

14?– World Chagas Disease Day

24 to 30?–?World Immunization Week

25?– World Malaria Day

?

May

15?– International Day of Families

23?–?International Day to End Obstetric Fistula

31?– World No Tobacco Day

?

June

5?– World Environment Day

8?– World Oceans Day

24??International Day of Women in Diplomacy

29?– International Day of the Tropics


Conferences

April

7 to 12??CGIAR Science Week

8 to 10?– Forecasting Healthy Futures Summit

24?– Global Inclusive Growth Summit

21 to 26?–?World Bank Spring Meetings

?

May

19 to 27?– World Health Assembly

?

June

12 to 14??World Conference on Gender Equality

21 to 29?–?London Climate Action Week

30 June to 3 July?– International Conference on Financing for Development


?

?

?

?


Rahima F. Dosani

Global Health | Healthcare Strategy

1 周

Thanks so much for highlighting our exciting work!

要查看或添加评论,请登录

Global Health Visions的更多文章